Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma

被引：0
|
作者：
Kenneth F. Koral
John P. Huberty
Bill Frame
Katherine K. Matthay
John M. Maris
Denise Regan
Daniel Normolle
Gregory A. Yanik
机构：
[1] University of Michigan,Department of Radiology, Nuclear Medicine Division
[2] University of California San Francisco,Department of Nuclear Medicine
[3] University of Michigan Comprehensive Cancer Center,Biostatistics Unit
[4] University of California San Francisco,Department of Pediatrics
[5] Children’s Hospital of Philadelphia,Department of Pediatrics
[6] University of Michigan,Department of Radiation Oncology
[7] University of Michigan,Department of Pediatrics
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2008年 / 35卷
关键词：
Dosimetry; Liver disease; Radionuclide therapy; Iodine-131; MIBG neuroblastoma oncology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2105 / 2112
页数：7
相关论文
共 50 条
  • [31] 131I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future past
    Fabozzi, Francesco
    Villani, Maria Felicia
    Del Bufalo, Francesca
    Altini, Claudio
    Cannata, Vittorio
    Davide, Ciucci
    Pizzoferro, Milena
    Drago, Margherita
    D'Antonio, Federica
    Triumbari, Elizabeth Katherine Anna
    Di Giannatale, Angela
    Vennarini, Sabina
    Mastronuzzi, Angela
    Ioris, Maria Antonietta De
    Garganese, Maria Carmen
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 207
  • [32] Hyperbaric oxygen for intensification of 131I MIBG therapy for refractory neuroblastoma stage 4
    Diehl, M
    Fusshoeller, G
    Menzel, C
    Kranert, WT
    Graichen, S
    Klingebiel, T
    Grünwald, F
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2004, 43 (06): : N77 - N80
  • [33] Radiation dosimetry of in vivo and vitro irradiation of I-131
    Kim, JH
    Kim, ES
    Kim, MS
    Lee, JY
    Kim, JS
    Lee, MC
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1421 - 1421
  • [34] Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)
    Zhou, Margaret J.
    Doral, Michelle Y.
    DuBois, Steven G.
    Villablanca, Judith G.
    Yanik, Gregory A.
    Matthay, Katherine K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2465 - 2472
  • [35] FDG PET/CT Versus I-131 MIBG in Neuroblastoma Osseous Infiltrates
    Abdelwahab, M. A.
    Kotb, M. H.
    Mostafa, H.
    Omar, W. M.
    Elsayd, H.
    Fawzy, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S602 - S603
  • [36] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Simon, Thorsten
    Eschner, Wolfgang
    Berthold, Frank
    Schicha, Harald
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1279 - 1290
  • [37] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Genolla, Jose
    Rodriguez, Trinidad
    Minguez, Pablo
    Lopez-Almaraz, Ricardo
    Llorens, Veronica
    Echebarria, Aizpea
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) : 1567 - 1575
  • [38] Value of SPECT/CT in Diagnostic I-131 MIBG Scintigraphy in Patients with Neuroblastoma
    Theerakulpisut D.
    Raruenrom Y.
    Wongsurawat N.
    Somboonporn C.
    Nuclear Medicine and Molecular Imaging, 2018, 52 (5) : 350 - 358
  • [39] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Jose Genolla
    Trinidad Rodriguez
    Pablo Minguez
    Ricardo Lopez-Almaraz
    Veronica Llorens
    Aizpea Echebarria
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1567 - 1575
  • [40] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Ferdinand Sudbrock
    Matthias Schmidt
    Thorsten Simon
    Wolfgang Eschner
    Frank Berthold
    Harald Schicha
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1279 - 1290
12345